Staphylococcus aureus (S. aureus) is a frequent cause of infections in both humans and animals.
| INTRODUCTION
Staphylococcus aureus (S. aureus) as a regular commensal of skin forms a part of the normal staphylococcal flora of humans and various animal species. S. aureus may turn into an extremely threatening pathogen when it traverses the epithelial barrier and gains access to internal tissues from where it can infect almost any organ and cause a broad spectrum of diseases including pneumonia, endocarditis, osteomyelitis, and sepsis (Barkema, Schukken, & Zadoks, 2006; Miller & Cho, 2011) .
S. aureus is also a major pathogen for mastitis both in cows and humans (Holmes & Zadoks, 2011) . Treatment of these infections has been complicated by its ability to persist in tissues and to evade the host immune response (Lowy, 1998; Wertheim et al., 2005) .
Adhesion to and invasion of host cells and even biofilm formation by S. aureus are mediated by microbial surface component recognizing adhesive matrix molecules (MSCRAMMs), which are the largest class of cell wall-anchored surface proteins (Foster, Geoghegan, Ganesh, & Höök, 2014) . The main function of MSCRAMMs is to promote adhesion by directly adhering to host cells or binding to extracellular matrix components and serum proteins, which then bind with receptors on target cells . The fibronectin-binding proteins FnBPA and FnBPB are two distinct but closely related multifunctional MSCRAMMs. They bind to fibronectin that acts as a bridge between S. aureus and the α5β1 integrin on host cells to promote S. aureus invasion (Agerer et al., 2005; Foster, 2016) .
Adhesion events are also crucial to biofilm formation. The ability to form and reside in biofilms is one of many reasons why S. aureus infection is difficult to eradicate (Otto, 2013) . In vivo, development of a biofilm is a two-step process involving an initial attachment mediated by the MSCRAMM adhesins and a subsequent maturation phase (Otto, 2008) . Biofilm-forming S. aureus displays an enhanced capacity to colonize and persist in the mammary glands (Cucarella et al., 2004) . In view of these, it might be effective to prevent S. aureus infection by inhibiting biofilm formation.
Lactic acid bacteria (LAB) used as probiotics have played an important role in preventing or treating infections induced by pathogenic bacteria in humans and animals (Ljungh & Wadstrom, 2006; Uehara et al., 2006) . In humans, use of probiotics to prevent vaginal infections and urinary tract infections has been investigated (de Souza & Olsburgh, 2008; Falagas, Betsi, Tokas, & Athanasiou, 2006) . In animals, intramammary infusion of live LAB was effective at alleviating chronic subclinical infections (Klostermann et al., 2008) . The mechanisms underlying these effects are not clear, but surface properties, production of hydrogen peroxide and organic acid, production of bacteriocin, and adhesion to host epithelium by LAB could be involved (Sikorska & Smoragiewicz, 2013) . It had been reported that LAB, such as Lactobacillus acidophilus, expressed cell surface proteins to bind fibronectin (Lorca, Torino, Font de Valdez, & Ljungh, 2002) . Two fibronectin-binding proteins (FbpA and FbpB) have been identified in Lactobacilli (Hymes, Johnson, Barrangou, & Klaenhammer, 2016; Muñoz-Provencio, Perez-Martinez, & Monedero, 2010) . Both proteins were homologous to fibronectin-binding proteins from streptococci.
The preventive effects of probiotics in mammary glands likely originate from their capacity to inhibit S. aureus colonization through competition with S. aureus for adhesion/attachment sites and/or nutrients and growth factors. For example, Bouchard, Rault, Berkova, Le Loir, and Even (2013) reported that Lactobacillus casei (L. casei) reduced adhesion of two bovine S. aureus strains to bovine mammary epithelial MAC-T cells (Bouchard et al., 2013) . Moreover, Lactobacillus reuteri and Lactobacillus rhamnosus reduced S. aureus induced keratinocyte cell death, possibly by blocking the α5β1 integrin on keratinocytes (Prince, McBain, & O'Neill, 2012) . Considering that the α5β1 integrin also exists in mammary epithelial cells (Taddei et al., 2003) , it is plausible that probiotics may block the same integrin to inhibit colonization of S. aureus and prevent S. aureus infections in mammary glands.
The goal of this work was to investigate the molecular mechanism to prevent S. aureus infections in mammary glands by LAB. LAB were isolated from milk samples and examined for their abilities to reduce S. aureus colonization in vitro and in vivo. Our results revealed that Weissella cibaria (W. cibaria) isolates carrying the fbpA gene inhibited the entry of S. aureus into the epithelial cells and the persistence in mammary glands. We also created mutants of W. cibaria isolate LW1 to confirm the involvement of FbpA in reducing S. aureus colonization in mammary glands.
| RESULTS

| Effects of LAB isolates on the adhesion of S. aureus into mammary epithelial cells in vitro
Probiotics may protect mammary glands by inhibiting adhesion of pathogens to epithelial cells. Therefore, the capacities of LAB isolates to prevent adhesion of S. aureus to bovine mammary epithelial cells (MAC-T cells) were first evaluated. The MAC-T cells were incubated with LAB isolates prior to infection of S. aureus. As shown in Figure 1 , adhesion of S. aureus to MAC-T cells was significantly reduced by 44.57%, 41.70%, and 28.84%, respectively, by three LAB isolates (W. cibaria LW1, W. cibaria LW2, and W. cibaria LW3), although other three LAB isolates (Enterococcus faecalis LS1, Enterococcus sp LS2, and Enterococcus hirae LS3) did not significantly affect the adhesion, in comparison with the positive control.
| Effects of LAB isolates on S. aureus induced infection within mammary glands
Our in vitro data clearly showed that three LAB isolates excluded S. aureus to reduce S. aureus adhesion of MAC-T cells, although other three did not. To investigate whether such effects also happened in vivo, six LAB isolates were introduced into the mammary glands of mice by intramammary infusion prior to the S. aureus challenge. The amount of S. aureus in the mammary tissue administered by S. aureus alone (the positive control) reached a high level of 7.54 ± 0.08 (log 10 CFU) at 16 hr post the challenge and then decreased slowly (Figure 2a ). Compared to the positive control, LW1, LW2, and LW3 reduced the S. aureus concentrations in mammary glands of mice by more than 98% at all five time points, although LS1, LS2, and LS3 were less effective ( Figure 2a ).
Our results above showed that LAB isolates protected the mammary glands through reducing the S. aureus colonization. To investigate the protective effects of LAB isolates on regulating the local host immune response, levels of proinflammatory cytokines TNF-α and IL-6 in mammary glands were measured by Enzyme7hyphen;Linked ImmunoSorbent Assay (ELISA). Infection with S. aureus alone (the positive control) led to a robust increase in TNF-α and IL-6 production compared to the negative control and peak concentrations of TNF-α FIGURE 1 Effects of LAB isolates on adhesion of S. aureus to mammary epithelial cells in vitro. Adhesion of S. aureus isolate E48 was measured after 2-hr incubation with MAC-T cells, which were preincubated with six LAB isolates (LW1, LW2, LW3, LS1, LS2, and LS3) for 2 hr. Adhesion was calculated as the ratio between the number of the adherent S. aureus population and the number of the added S. aureus population per well. An adhesion assay of S. aureus in the absence of LAB isolates was used as a control. Data are presented as means ± standard deviations. The statistical analysis was performed using a one-way analysis of variance (ANOVA) with the least significant difference (LSD) test. *P < .05 in comparison with the control group. S. aureus = Staphylococcus aureus (30.04 ± 0.22 ng/g) and .47 pg/g) were observed at 8 and 16 hr, respectively (Figure 2b and 2c) . Compared to the positive control, the six LAB isolates had similar abilities to decrease the levels of TNF-α and IL-6 significantly at 8, 16, and 24 hr. At 48 and 72 hr, however, LW1, LW2, and LW3 decreased the concentrations of TNF-α and IL-6 by more than 59%, while LS1, LS2, and LS3 only decreased by less than 40% (Figure 2b and 2c) . These in vivo results demonstrated that LW1, LW2, and LW3 had better effects on protecting mammary glands against S. aureus infection than LS1, LS2, and LS3.
2.3 | Lack of fbpA impaired the adhesion function of inhibitory W. cibaria isolates
The above findings suggested that our LAB isolates could be divided into two types: one that efficiently inhibited adhesion of S. aureus (high-inhibitory type, LW1, LW2, and LW3) and the other that was less inhibitory (low-inhibitory type, LS1, LS2, and LS3). We measured Fnbinding phenotype of each strain using fibronectin-binding assay: 2.5 | W. cibaria FbpA was responsible for inhibiting biofilm formation of S. aureus in vitro
Biofilm plays an important role in S. aureus infections. S. aureus is a biofilm producer, although LAB isolates are generally regarded as nonbiofilm formation strains. To investigate whether W. cibaria FbpA had any effects on biofilm formation of S. aureus, three W. cibaria isolates containing the fbpA gene and two mutants were used. As shown in Figure 4a , these 3 isolates significantly reduced biofilm formation.
On the other hand, LW1ΔfbpA did not show any biofilm-inhibition activity. However, the inhibitory activity was restored in LW1ΔfbpA (FbpA; Figure 4b ). Furthermore, with the addition of the purified FbpA, the biofilm formation of S. aureus was also reduced significantly ( Figure 4c) . A twofold dilution series of the fusion protein SlpFbpA was used (1, 2, 4, and 8 μg) to bind to the surface of LW1ΔfbpA. Adhesion percentages were calculated as the ratio between the number of the adherent LAB strain population and the number of the added LAB population per well. An adhesion assay of LW1 (wild type) was used as a control. (b) Binding of S. aureus to fibronectin. The purified FbpA was added into the wells precoated with fibronectin (a twofold dilution series) prior to the addition of S. aureus isolate E48. An adhesion assay of S. aureus alone was used as a control (open bars). (c) The adhesion percentages of S. aureus to MAC-T cells were measured after 2-hr incubation with MAC-T cells, which were preincubated with different strains (LW1, LW1ΔfbpA, and LW1ΔfbpA [FbpA]) for 2 hr. Adhesion percentages were calculated as the ratio between the number of the adherent S. aureus population and the number of the added S. aureus population per well. An adhesion assay of S. aureus in the absence of Weissella cibaria isolates was used as a control. Data are presented as means ± standard deviations. The statistical analysis was performed using a one-way analysis of variance (ANOVA) with the least significant difference (LSD) test. *P < .05 in comparison with the control group. S. aureus = Staphylococcus aureus 2.6 | W. cibaria FbpA hindered S. aureus colonization in mammary glands
With the purpose to determine the effect of W. cibaria FbpA on S. aureus colonization in mammary glands in vivo, the mammary glands of mice were injected with LW1, LW1ΔfbpA, or LW1ΔfbpA (FbpA) 2 hr before challenge with S. aureus. As shown in Figure 5 , the wild-type LW1 was the most effective in reducing S. aureus colonization, with LW1ΔfbpA least effective and LW1ΔfbpA (FbpA) in the middle. This exclusion mechanism was also verified by in vivo experiments. The mouse mastitis model was used to determine the preventive effect of LAB isolates against S. aureus infection. In our study, significant reductions in concentrations of S. aureus and levels of proinflammatory cytokines in mammary glands were observed with introduction of LAB isolates into the mammary glands prior to the S. aureus challenge (Figure 2 ). These results indicated the potential of using LAB isolates to prevent S. aureus infection in mammary glands.
The major finding of this study was that a fibronectin-binding protein (FbpA) of W. cibaria isolates was responsible for reducing S. aureus colonization and infection in mammary glands. It is interesting that the fbpA gene was found in the inhibitory W. cibaria isolates, but not in the low-FIGURE 4 Effects of LW1, its mutants, and FbpA on biofilm formation of S. aureus. (a) Inhibition of S. aureus biofilm formation by inhibitory Weissella cibaria isolates. S. aureus Isolate E48 was cultured alone (filled bars) or coincubated with the inhibitory type of Weissella cibaria isolates (LW1, LW2, or LW3). After 8, 16, and 24 hr of culture, the amount of S. aureus biofilm mass was measured. (b) Effects of LW1, LW1ΔfbpA, LW1ΔfbpA (FbpA), and (c) purified FbpA on the biofilm formation of S. aureus. Data are presented as means ± standard deviations. The statistical analysis was performed using a one-way analysis of variance (ANOVA) with the least significant difference (LSD) test. *P < .05 in comparison with the control group of S. aureus isolate E48 alone. S. aureus = Staphylococcus aureus FIGURE 5 Effect of LW1 and its mutants on S. aureus colonization in mammary glands of mice. LW1, LW1ΔfbpA, or LW1ΔfbpA (FbpA) was individually injected into the mammary glands of mice 2 hr prior to the challenge of S. aureus isolate E48. The intramammary concentrations of S. aureus were measured after 8, 16, 24, 48, and 72 hr of the challenge. A group of mice injected with S. aureus alone was used as a positive control. Data are presented as means ± standard deviations. The statistical analysis was performed using a one-way analysis of variance (ANOVA) with the least significant difference (LSD) test. *P < .05 in comparison with the positive control group. S. aureus = Staphylococcus aureus inhibitory-type LAB isolates in our work. The FbpA was predicted to contain a typical domain for binding fibronectin and its binding ability was confirmed with immobilized fibronectin. However, the FbpA from our isolates, KACC 11862 and BL23 belong to an atypical group of fibronectin-binding proteins that lack the secretion and cell-wall anchoring (Sinha et al., 1999) . In addition, FnBPs were involved in the processes of colonization of S. aureus into mouse mammary glands (Brouillette, Talbot, & Malouin, 2003) . In our work, addition of the purified FbpA significantly reduced the adherence of S. aureus to immobilized fibronectin ( Figure 3b) . The W. cibaria isolates containing the fbpA gene significantly reduced the adhesion of S. aureus to mammary epithelial cells (Figure 1 ). S. aureus isolates used in our study contained the fnbA or fnbB gene for encoding FnBPs (data not shown). In addition, both LW1ΔfbpA and LW1ΔfbpA (FbpA) were constructed to confirm the effects of FbpA on reducing S. aureus colonization in vitro and in vivo ( Figure 3c and Figure 5 ). All these support the notion that W. cibaria FbpA bound to fibronectin and the complex then interacted with the α5β1 integrin on mammary epithelial cells (Taddei et al., 2003) . Consequently, W. cibaria isolate LW1 reduced the S. aureus colonization and infection in mammary glands though interfering with the fibronectin-binding proteins-mediated invasion pathway by S. aureus (Figure 6a and 6b) .
Staphylococcus aureus biofilm has been widely investigated due to its ability to help bacteria escape the host defense system (Melchior, 2011) . Staphylococcus epidermidis has been shown to inhibit the biofilm formation of S. aureus through a mechanism of bacterial interference (Iwase et al., 2010) . However, few studies determined the ability of probiotics to inhibit the biofilm formation of S. aureus. In our study, we measured the biofilm formation of all the six LAB isolates. They were nonadherent strains (OD 595 ≤ 0.200) and they did not form biofilm. Our result was consistent with the study that reported that some LAB could not form biofilm (Kawarai, Furukawa, Ogihara, & Yamasaki, 2007) . We showed that three W. cibaria isolates containing the fbpA gene inhibit biofilm formation of S. aureus (Figure 4a ). This was consistent with results from a previous study, even though different probiotic strains were used (Vuotto, Longo, & Donelli, 2014) . Furthermore, the LW1ΔfbpA (FbpA) and purified FbpA also had an inhibition activity on biofilm formation of S. aureus in vitro (Figure 4b and 4c) . These results together supported our speculation that W. cibaria In this work, we have provided concrete evidence to explain the molecular mechanism for probiotics to exclude S. aureus from its 
| Mammary epithelial cells and culture conditions
The established bovine mammary epithelial cell (MAC-T) line (Huynh, Robitaille, & Turner, 1991) has been used for invasion assays (Almeida, Matthews, Cifrian, Guidry, & Oliver, 1996) and thus was retained for this study. MAC-T cells were cultured in 9-cm cell culture plates using MAC-T medium: Dulbecco's Modified Eagle Medium (DMEM) containing 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, 10 mg/ ml streptomycin. Cells were incubated at 37°C in a humidified incubator with 5% CO 2 . They were cultured to a confluent monolayer, treated with 0.25% trypsin, and suspended in fresh MAC-T medium.
For adhesion assays, cells were then seeded in 24-well plates and incubated at 37°C in 5% CO 2 to obtain a confluent monolayer for 3 days.
| Adhesion assays
The bacterial strains or isolates used in this study are listed in Table 1. LAB LW1, 2, 3, LS1, 2, and 3 were isolated from milk using the MRS medium under anaerobic environment and were identified by 16S rDNA sequence analyses. They are isolates in our laboratory and not established strains. The number of LAB isolate population was determined after incubation anaerobically for 48 hr at 37°C on the MRS agar. The number of the S. aureus population was determined after 24 hr of incubation at 37°C on the Baird-Parker agar.
Adhesion assays were adapted from Bianchi et al. (2004) and Cantinieaux, Hariga, Courtoy, Hupin, and Fondu (1989) with minor modifications. Confluent monolayers of MAC-T cells were washed three times with phosphate-buffered saline (PBS) and incubated in antibiotic-free DMEM at 37°C in 5% CO 2 . The S. aureus isolate E48 or LAB isolate was labeled with fluorescein isothiocyanate and kept in a dark place for 2 hr at 37°C, then washed three times with PBS to remove free fluorescein isothiocyanate and resuspended in 1 ml PBS. One hundred microlitres of labeled bacterial suspension was transferred to 24-well plates containing the MAC-T cells (2 × 10 5 cells/well) at an MOI of 10:1 (S. aureus) or 100:1 (LAB). The mixture was incubated for 2 hr.
For the adhesion inhibition assay, cells were first incubated with unlabeled LAB at an MOI of 10:1 for 2 hr and washed twice with PBS prior to infection with labeled S. aureus at an MOI of 10:1 for additional 2 hr. After incubation, unadherent bacteria were washed out by PBS for three times and 200 μl of trypsin was used to digest the cell and adherent bacteria. Two hundred microlitres of the cell and bacteria mixture was added to 96-well plates for quantification of fluorescence with excitation wavelength at 492 nm and emission wavelength at 518 nm to estimate the adhesion.
Adhesion percentages were calculated as the ratio between the adherent bacterial number and the added bacterial number per well.
| Biofilm formation analysis
The biofilm formation of S. aureus in the presence or absence of LAB in microtiter wells was performed as described (Vergara-Irigaray et al., 2009 ) with the follow modification. In brief, S. aureus isolate E48 and each LAB isolate were overnight cultured and diluted 1:200 in a test medium (a mixture of equal volume of BHI and MRS with 5% sucrose; Kang, Chung, Kim, Yang, & Oh, 2006) , and 200 μl of this cell suspension was added into one well of sterile 96-well polystyrene microtiter plates. S. aureus alone without LAB was used as a positive control.
After 8, 16, or 24 hr of incubation at 37°C, the wells were washed three times with sterile PBS to remove nonadherent cells, dried in an inverted position, and stained with 0.1% crystal violet for 5 min. Wells were rinsed again, and the absorbance was determined at 595 nm.
| Mouse intramammary infection
Six-to eight-week-old specific-pathogen-free BALB/c mice were purchased from the Experimental Animal Center of the Medical College of Xi'an Jiao Tong University. To observe the protective effect of LAB isolates on S. aureus infection in mammary glands, experiments were performed with eight treatment groups: one positive control (S. aureus isolate E48 only), one negative control (PBS only), and 6 treatment groups (LAB + S. aureus isolate E48). Fifteen lactating mice were randomly divided into each group (3 per time point). The mice were challenged intramammarily with S. aureus or injected with LAB as described (Kerr et al., 2001) . On the day of the challenge, the mothers between days 7 and 15 of lactation were separated from their pups for 4 hr.
After that, pups were allowed to nurse for 1 hr in order to deplete mammary glands of milk. (fbpA-V583-F/fbpA-V583-R; Torelli et al., 2012) , and the fnm gene (encoding a fibronectin-binding protein similar to FbpA) in Enterococcus faecium TX82 (fbpA-TX82-F/fbpA-TX82-R; Somarajan et al., 2015) respectively.
To delete the fbpA gene from the genome of W. cibaria isolate LW1, a homologous recombination procedure was performed employing the suicide vector pUC19 (Pang, Cui, Liu, Zhang, & Lv, 2014) . DNA fragments for 630 BP upstream and 670 BP downstream of fbpA gene were amplified using the specific primer pairs fbpAUp-F/fbpAUp-R and fbpADown-F/fbpADown-R, respectively, ( Table 2) .
and cloned into pUC19 with digestion and ligation. An erythromycin resistance marker, the emr gene, was amplified from pMG36e with the primer pair EmrF/EmrR (Table 2) .and inserted between upstream and downstream of the fbpA gene to produce the recombinant plasmid pUC19-fbpA::emr.
For knocking-out of the fbpA gene, the pUC19-fbpA::emr plasmid and fbpA-F2&fbpA-R2 (Table 2) . (Table 2) .
from plasmid pMG36e-Slp1 and pEASY-T5-FbpA, respectively.
Overlap PCR was performed to fuse Slp and fbpA fragments. The fbpA fragment and the fusion DNA fragment were cloned into pET28a with T7 promoter to construct expression vectors pET28-FbpA and pET28-SlpFbpA, respectively.
Gene expression was carried out as described in the pET system Manual (Novagen, USA) by using E. coli strain BL21 (DE3). The overnight culture of strains harboring the expression vectors was diluted 1:50 in fresh LB broth containing kanamycin (50 μg/ml) and cultured with vigorous shaking at 37°C to an OD 600 of 0.6. Expression of the fusion protein was induced by the addition of Isopropyl-β-Dthiogalactopyranoside to 0.2 mM. Cells were grown for 8 hr at 30°C and harvested by centrifugation.
All purification steps were carried out on ice. Cells (BL21 strains containing pET28-FbpA or pET28-SlpFbpA) were disrupted by an ultrasonic processor. The supernatant containing soluble FbpA or fusion protein SlpFbpA was collected by centrifugation at 13,000 g for 20 min and resuspended in a binding buffer (20 mM NaH 2 PO 4 , 500 mM NaCl, 15 mM imidazole, pH 7.4). Purification was performed according to the instructions of the HisTrap HP column (GE Healthcare, USA).
4.8 | Binding of SlpFbpA fusion proteins to W. cibaria isolate LW1ΔfbpA
FbpA is considered as an atypical fibronectin-binding protein that lacks the secretion and cell-wall-anchoring sequences (Muñoz-Provencio et al., 2010) . If the wild-type gene fbpA was used for the complementation, it will not be secreted and located on the bacterial surface. To display FbpA on the cell surface of LW1ΔfbpA, the SlpFbpA fusion protein containing the signal peptide and the cell wall anchor was used to coincubate with LW1ΔfbpA.
The binding of SlpFbpA fusion protein to LW1ΔfbpA was performed as described (Hu et al., 2011) . LW1ΔfbpA (1.0 × 10 6 CFU) was collected, washed twice, and resuspended in 100 μl of PBS.
For binding, the bacteria in 100 μl of PBS were incubated for 1 hr at 37°C with purified SlpFbpA fusion proteins in different concentrations. After binding, cells were collected by centrifugation at 10,000 g for 5 min and resuspended in 100-μl PBS with a vortex mixing.
| Fibronectin-binding assays
Fibronectin-binding assays were performed as described (Geoghegan, Monk, O'Gara, & Foster, 2013; Peacock, Day, Thomas, Berendt, & Foster, 2000) with slight modifications. Microtiter plates were coated with a solution of fibronectin (20 μg/ml) and incubated overnight at 4°C. The plates were then washed three times in sterile PBS and blocked for 2 hr at 37°C with 5% Bovine Serum Albumin (BSA). One hundred microlitres of each strain was added to each well in PBS adjusted to an OD 600nm of 1.0, and plates were incubated for 2 hr at 37°C. The wells were then washed three times with sterile PBS and fixed with 25% formaldehyde. Wells containing PBS without bacteria were used as a negative control in all assays. Finally, wells were washed once with sterile PBS, stained with 0.4% crystal violet, and quantified by measuring the A 570 of crystal violet, which had been solubilized in 5% acetic acid.
4.10 | Accession numbers for genes or proteins mentioned in text fbpA in LW1 (LW2): KU302759; fbpA in LW3: KU302760.
